Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, and meningitis in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious Gram‑negative and Gram‑positive infections.

Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure in patients with intra‑abdominal sepsis. Complicated urinary tract infections: eliminates pathogenic organisms and resolves infection symptoms. Hospital‑acquired pneumonia: achieves microbiological clearance and improves respiratory function. Ventilator‑associated pneumonia: restores lung health and reduces mortality risk. Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. Severe sepsis and septic shock: rapidly reduces bacterial load to support hemodynamic recovery.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea - Diarrhea - Headache - Rash or pruritus - Elevated liver enzymes (ALT, AST) - Injection‑site pain or phlebitis

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders - Clostridioides difficile‑associated colitis - Anaphylactic or severe hypersensitivity reactions - Acute renal failure or nephrotoxicity - Severe neutropenia or thrombocytopenia - Hepatic failure or jaundice

Careful assessment and monitoring are essential when using Meropenem. - Renal function: evaluate creatinine clearance and adjust dose as needed. - Seizure risk: avoid in patients with a history of epilepsy or CNS disease. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Hypersensitivity: discontinue if signs of an allergic reaction appear. - Concomitant nephrotoxic drugs: use with caution to prevent renal injury. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: carbapenems can lower valproate levels, risking seizure breakthrough. - Probenecid: may reduce renal clearance of Meropenem, increasing toxicity. - Aminoglycosides: combined use can enhance nephrotoxic potential.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR as Meropenem may alter anticoagulant effect. - Oral contraceptives: efficacy may be reduced; advise alternative contraception.